Abstract
Serum levels of ursodeoxycholic acid (UDCA) were measured by radioimmunoassay in 20 children with cystic fibrosis (CF) and in eight controls, who had received 300 mg of this bile acid orally. Area under the curve (AUC) after UDCA load was significantly reduced (25.24±9.54) in CF patients, as compared to controls (52.98±5.87 mean values±sd percent dose/literxhrxkg body weight, P
| Original language | English |
|---|---|
| Pages (from-to) | 306-311 |
| Number of pages | 6 |
| Journal | Digestive Diseases and Sciences |
| Volume | 28 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Apr 1983 |
ASJC Scopus subject areas
- Gastroenterology
Fingerprint Dive into the research topics of 'Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosis'. Together they form a unique fingerprint.
Cite this
Colombo, C., Roda, A., Roda, E., Sereni, L. P., Maspero, D., Giunta, A. M., & Barbara, L. (1983). Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosis. Digestive Diseases and Sciences, 28(4), 306-311. https://doi.org/10.1007/BF01324946